1. 106604919 6‑((6,7‑二甲氧基喹唑啉‑4‑基)氧基)‑N,2‑二甲基苯并呋喃‑3‑甲酰胺晶型
CN
26.04.2017
C07D 405/12 Loading...
C07D 405/12
Loading...
201580047368.6
和记黄埔医药(上海)有限公司
吴振平
C07D 405/12
Loading...
本发明涉及药学领域，提供了化合物6‑((6,7‑二甲氧基喹唑啉‑4‑基)氧基)‑N,2‑二甲基苯并呋喃‑3‑甲酰胺的新晶型、溶剂合物及其晶型、其药物组合物，及其制备方法和应用。
2. 106432225 某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和其使用方法
CN
22.02.2017
C07D 471/04 Loading...
C07D 471/04
Loading...
201610432059.7
和记黄埔医药（上海）有限公司
苏慰国
C07D 471/04
Loading...
本发明涉及某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和其使用方法，所述化合物可用于抑制c‑Met的活性和治疗对抑制c‑Met敏感的癌症。
3. 104640862 新的杂芳基和杂环化合物、其组合物及方法
CN
15.02.2017
C07D 473/34 Loading...
C07D 473/34
Loading...
112013000039914
和记黄埔医药（上海）有限公司
苏慰国
C07D 473/34
Loading...
本发明公开了新的式I‑1、I‑2或I‑3的杂芳基和杂环化合物、包含它们的药物组合物，以及它们在抑制PI3K的活性及治疗炎性疾病、自身免疫性疾病和癌症中的用途和方法。
4. 102906092 某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和其使用方法
CN
03.08.2016
C07D 487/04 Loading...
C07D 487/04
Loading...
112010000065014
和记黄埔医药（上海）有限公司
苏慰国
C07D 487/04
Loading...
提供了某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和使用其的方法。
5. 105726561 板蓝根多糖在制备用于预防或治疗流感病毒诱导的炎症性疾病的药物中的应用及制备的药物
CN
06.07.2016
A61K 31/715 Loading...
A61K 31/715
Loading...
102016000071191
广州医科大学附属第一医院
杨子峰
A61K 31/715
Loading...
本发明公开了一种板蓝根多糖在制备用于预防或治疗流感病毒诱导的炎症性疾病的药物中的应用，以及一种用于预防或治疗流感病毒诱导的炎症性疾病的药物组合物，所述药物组合物中，按重量百分比计含有1％～99％的板蓝根多糖。本发明为临床治疗流感病毒性疾病提供了一种安全有效、毒副作用小的药物。
6. 105646414 6-羟基-2-甲基苯并呋喃类化合物的合成方法
CN
08.06.2016
C07D 307/79 Loading...
C07D 307/79
Loading...
201410630860.3
和记黄埔医药（苏州）有限公司
葛崇峰
C07D 307/79
Loading...
本发明涉及6-羟基-2-甲基苯并呋喃类化合物的合成方法。本发明属于医药中间体领域，更具体而言，本发明涉及一种合成6-羟基-2-甲基苯并呋喃类化合物的方法。6-羟基-2-甲基苯并呋喃类化合物是一类重要的医药中间体，可用于制备多种抗癌药物。
7. 105461702 6-(6,7-二甲氧基喹唑啉-4-基氧基)-N,2-二甲基苯并呋喃-3-甲酰胺晶型
CN
06.04.2016
C07D 405/12 Loading...
C07D 405/12
Loading...
201410456350.9
和记黄埔医药(上海)有限公司
吴振平
C07D 405/12
Loading...
本发明属于药学领域，提供了化合物6-(6,7-二甲氧基喹唑啉-4-基氧基)-N,2-二甲基苯并呋喃-3-甲酰胺的晶型、溶剂合物及其晶型、其药物组合物，及其制备方法和应用。
8. 105143185 新的嘧啶和吡啶化合物以及它们的用途
CN
09.12.2015
C07D 213/04 Loading...
C07D 213/04
Loading...
201480015314.7
和记黄埔医药(上海)有限公司
苏慰国
C07D 213/04
Loading...
本发明涉及式(I)的新的嘧啶和吡啶化合物或其药学上可接受的盐，其中R1、R2、R3、R4、R5、X、Y和G如说明书中所定义，并且涉及含有它们的药物组合物、制备它们的方法和它们在治疗对抑制FGFR有响应的疾病例如癌症中的用途。
9. 103596952 作为Syk抑制剂的新型取代的吡啶并吡嗪类化合物
CN
19.02.2014
C07D 471/04 Loading...
C07D 471/04
Loading...
201280027852.9
和记黄埔医药(上海)有限公司
苏慰国
C07D 471/04
Loading...
本发明提供了式(I)的吡啶并吡嗪类化合物、其药物组合物及其用途，其中R1、R2、R3、R4和m如说明书中所定义。
10. 103124731 稠合的杂芳基化合物及其应用
CN
29.05.2013
C07D 471/04 Loading...
C07D 471/04
Loading...
201180044818.8
和记黄埔医药(上海)有限公司
苏慰国
C07D 471/04
Loading...
本发明提供了稠合的杂芳基化合物、其组合物及其用途。
11. 103119045 吡咯并嘧啶化合物及其用途
CN
22.05.2013
C07D 487/04 Loading...
C07D 487/04
Loading...
201180040092.0
和记黄埔医药(上海)有限公司
苏慰国
C07D 487/04
Loading...
本申请公开了能抑制JAK激酶的式(I)的吡咯并嘧啶化合物，其中R1、R2和m如说明书中所定义。还公开了含有所述吡咯并嘧啶化合物的药物组合物和所述吡咯并嘧啶化合物在治疗障碍或疾病如炎性疾病和癌症中的用途。
12. 102906086 喹唑啉化合物
CN
30.01.2013
C07D 403/14 Loading...
C07D 403/14
Loading...
201180024971.4
和记黄埔医药(上海)有限公司
张维汉
C07D 403/14
Loading...
本发明提供了某些喹唑啉化合物、其组合物及其使用方法。这些喹唑啉化合物能有效地抑制表皮生长因子受体(EGFR)的过量表达和/或过度活性。
13. 102906092 某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和其使用方法
CN
30.01.2013
C07D 487/04 Loading...
C07D 487/04
Loading...
201080065014.1
和记黄埔医药（上海）有限公司
苏慰国
C07D 487/04
Loading...
本发明提供了某些三唑并吡啶化合物和三唑并吡嗪化合物、其组合物和使用其的方法。
14. 102399218 一类并合三杂环及其作为PI3K抑制剂的用途
CN
04.04.2012
C07D 471/04 Loading...
C07D 471/04
Loading...
201010281157.8
和记黄埔医药（上海）有限公司
苏慰国
C07D 471/04
Loading...
本发明提供了一类并合三杂环及其作为PI3K抑制剂的用途。本发明还提供了含有所述并合三杂环化合物的药物组合物及其在治疗肿瘤等疾病中的应用。
15. 102372717 吡咯并嘧啶类化合物及其用途
CN
14.03.2012
C07D 487/04 Loading...
C07D 487/04
Loading...
201010257786.7
和记黄埔医药(上海)有限公司
苏慰国
C07D 487/04
Loading...
本发明提供了吡咯并嘧啶类化合物及其用途。具体地，本发明提供了一类具有JAK激酶抑制活性的吡咯并嘧啶类化合物。本发明还提供了含有所述吡咯并嘧啶类化合物的药物组合物及其在治疗炎症性疾病和癌症等疾病中的应用。
16. 102311438 喹唑啉化合物
CN
11.01.2012
C07D 487/04 Loading...
C07D 487/04
Loading...
201010217206.1
和记黄埔医药(上海)有限公司
张维汉
C07D 487/04
Loading...
本发明提供了一类喹唑啉化合物。具体地，本发明提供了一类具有抑制EGFR过度表达和/或活性过高的喹唑啉化合物。本发明还提供了含有所述喹唑啉化合物的药物组合物及其在治疗癌症方面的应用。
17. 102127096 Triazole pyridine and triazole pyrazine compound and composition and application thereof
CN
20.07.2011
C07D 519/00 Loading...
C07D 519/00
Loading...
200910247948.6
Hutchison MediPharma Limited.
Su Weiguo
C07D 519/00
Loading...
The invention provides a triazole pyridine and triazole pyrazine compound and a composition and application thereof.
18. 102070618 Compound and crystals thereof
CN
25.05.2011
C07D 403/12 Loading...
C07D 403/12
Loading...
200910199259.2
Hutchison MediPharm (Shanghai) Limited
Su Weiguo
C07D 403/12
Loading...
The invention discloses a pyrimidine compound of a structural formula A. The structural formula A is shown below. The pyrimidine compound can be used for preparing medicaments for treating diseases associated with vasculogenesis, in particular medicaments for treating tumor, age-related macular degeneration or autoimmune diseases.
19. 101659659 Pyridine derivative and medical application thereof
CN
03.03.2010
C07D 405/12 Loading...
C07D 405/12
Loading...
200810042214.X
Hutchison MediPharm Limited
Su Weiguo
C07D 405/12
Loading...
The invention discloses a pyridine derivative of a structural formula (I), wherein the structural formula (I) is as shown on the right. The pyridine derivative can be used for preparing medicaments for treating diseases related to blood vessels, particularly for preparing the medicaments for treating tumors, age-related macular degeneration or chronic inflammatory diseases.
20. 101619043 Quinazoline derivant and medical application thereof
CN
06.01.2010
C07D 239/94 Loading...
C07D 239/94
Loading...
200810039831.4
Hutchison MediPharm Limited
Zhang Weihan
C07D 239/94
Loading...
The invention discloses a quinazoline derivant as shown in the structural formula (I), wherein the structural formula (I) is as shown in the right formula. The quinazoline derivant can be used for preparing medicaments for treating tumors.
21. 101575333 Quinazoline derivatives and medical application thereof
CN
11.11.2009
C07D 405/12 Loading...
C07D 405/12
Loading...
200810037240.3
Hutchison MediPharm (Shanghai) Co., Ltd.
Su Weiguo
C07D 405/12
Loading...
The invention discloses a quinazoline derivatives of structural formula (I). The quinazoline derivatives can be used for preparing medicaments for diseases correlative to angiogenesis, particularly, can be used for preparing medicaments for treating tumor, age-related macular degeneration or chronic inflammation.
22. 101422494 Creat extract and medical use thereof
CN
06.05.2009
A61K 36/19 Loading...
A61K 36/19
Loading...
200710047765.0
Hutchison MediPharma (Shanghai) Limited
Yan Xiaoqiang
A61K 36/19
Loading...
The invention belongs to the medicament science field and discloses an andrographis paniculata extract and a preparation method thereof. The invention also discloses a drug combination containing the andrographis paniculata extract, and the application of the andrographis paniculata extract.
23. 101423518 Imidazole derivates and medical use thereof
CN
06.05.2009
C07D 487/04 Loading...
C07D 487/04
Loading...
200810175305.0
Hutchison MediPharma (Shanghai) Limited
Su Weiguo
C07D 487/04
Loading...
The invention relates to an imidazole derivative and medicinal application thereof. The invention discloses a compound in structural formula I, and definitions of all variable groups are described in instruction. The invention relates to a method for reducing level of intraindividual cell factors (such as TNF alpha or IL-1 beta) by the compound in the structural formula I. The invention also relates to a method for treating diseases mediated by hypertrophy of cell factors by the compound in the structural formula I.
24. 101289444 Pyrimidine derivate and medicinal use thereof
CN
22.10.2008
C07D 403/12 Loading...
C07D 403/12
Loading...
200710039509.7
Hutchison MediPharma (Shanghai) Limited
Su Weiguo
C07D 403/12
Loading...
The invention discloses a pyrimidine derivative as the formula (I), wherein, the formula (I) is shown as the right, the pyrimidine derivative can be used for preparing medicines for treating related diseases of angiogenesis, particularly used for preparing medicines for treating tumors or the aging macular degeneration.
25. 101200465 Decahydronaphthalene compounds and medical uses thereof
CN
18.06.2008
C07D 407/06 Loading...
C07D 407/06
Loading...
200610119360.9
Heji Huangpu Medicine(Shanghai) Co., Ltd.
Su Weiguo
C07D 407/06
Loading...
The invention discloses a compound in the formula I. The compound can be used to prepare TNF Alpha, IL-1 Beta or iNOS expression inhibitor and NF-Kappa B activity inhibitor, and also used to prepare the drug for the treatment or the prevention of the autoimmune diseases, the tumor or the arteriosclerosis.
26. 101125836 Costene lactone derivative and medical use thereof
CN
20.02.2008
C07D 307/77 Loading...
C07D 307/77
Loading...
200610030092.3
Heji Huangpu Medicine(Shanghai ) Co., Ltd.
Su Weiguo
C07D 307/77
Loading...
The invention provides a compound as shown in a structure formula (I). The compound can be used for inhibiting the expression of TNF Alpha, IL-1 Beta and iNOS or the activity of NF- Kappa B, thereby preventing or curing diseases that are related to the high expression of TNF Alpha, IL-1 Beta and iNOS and high activity of NF- Kappa B, such as autoimmune diseases, tumor or arteriosclerosis, etc.
27. 101091707 Medicinal usage of kuhseng extractive
CN
26.12.2007
A61K 31/352 Loading...
A61K 31/352
Loading...
200610028072.2
Hejihuangpu Medicines (Shanghai) Co., Ltd.
Zhang Weihan
A61K 31/352
Loading...
The present invention belongs to the field of medicine, and discloses an application of flavescent sophora flavone compound or its mixture. It can be used for preparing inhibitor for inhibiting NF-kB, EGFR, Her-2 or KDR activity. Further, said flavescent sophora flavone compound or its mixture can be used for preparing medicine for curing the diseases of tumor or inflammation resulted from high-expression or high-activity of NF-kB, EGFR, Her-2 or KDR.
28. 101062911 Dihydro quinone compounds and preparation method and medicinal usage thereof
CN
31.10.2007
C07C 323/20 Loading...
C07C 323/20
Loading...
200610026175.5
Hutchison MediPharm (shanghai) Limited
Zhang Weihan
C07C 323/20
Loading...
The invention discloses a dihydride quinone compounds as structural formula (I) and preparing method and application of the medicine to prevent or treat tumor.
29. 101028318 Sustained andrographis paniculata preparation and its preparing method
CN
05.09.2007
A61K 36/19 Loading...
A61K 36/19
Loading...
200610058087.3
Heji Huangpu Medical Enterprise Co., Ltd.
Wang Yuqing
A61K 36/19
Loading...
A slow-release medicine of green chiretta is proportionally prepared from powdered extract of green chiretta, retarder, pore-forming agent, filler, lubricant, and flowing aid. Its preparing process is also disclosed.
30. 1781479 Chinese small iris seed agent dispersion system and its preparing method
CN
07.06.2006
A61K 31/122 Loading...
A61K 31/122
Loading...
200410100136.6
Heji Huangpu Medicine Enterprise Co., Ltd.
Liu Zhongzhou
A61K 31/122
Loading...
The present invention relates to a kind of dispersed sword iris seed essence system comprising sword iris seed essence in effective treating amount, at least two kinds of surfactant in the weight ratio to the sword iris seed essence of 0.01-0.3, and at least one kind of absorbent in the weight ratio to the sword iris seed essence of 0.5-10. The present invention also discloses the preparation process of the dispersed sword iris seed essence system, which may be prepared into dispersant tablet, granule, capsule and other forms for oral taking. After being dispersed, the suspended particle is fine and has excellent flowability.
31. 1781478 Use of lushan rabdosia A agent and its derivatives analog in preparing anti-cancer medicine
CN
07.06.2006
A61K 31/122 Loading...
A61K 31/122
Loading...
200410095579.0
Heji Huangpu Medicine Enterprise Co., Ltd.
Huang Weihui
A61K 31/122
Loading...
The present invention relates to the pharmaceutical use of Lushan rubescensin A and its derivatives and analogs, and is especially the use of Lushan rubescensin A, Lushan rubescensin B and Lushan rubescensin E in preparing anticancer medicine. The present invention develops the new pharmaceutical use of Lushan rubescensin A and its derivatives and analogs.
32. 1771931 Use of diterpene compound in preparingmedicines with synergistic effect to chemical therepy medicines
CN
17.05.2006
A61K 31/215 Loading...
A61K 31/215
Loading...
200410088934.1
Hutchison Whampoa Medi Pharma Limited
Huang Weihua
A61K 31/215
Loading...
The present invention relates to the pharmaceutical use of diterpene compound with the general expression as shown or its precursor medicine, and is especially the use of the diterpene compound or its precursor medicine in preparing medicine with synergistic effect on tumor chemotherapy medicine.
33. 1711995 Use of Chinese small iris seed extract A and its derivative and analogs in preparation of anti-cancer medicine
CN
28.12.2005
A61K 31/122 Loading...
A61K 31/122
Loading...
200410049698.2
Hutchison Whampoa Pharmaceutics Enterprise Co., Ltd.
Cui Yumin
A61K 31/122
Loading...
An application of the irisin A and irisin B in preparing antineoplastic medicines is disclosed.
34. 1711994 Use of Chinese small iris seed extract A and its derivative and similar materials in preparation of chemical therapeutical sensitizing agent
CN
28.12.2005
A61K 31/122 Loading...
A61K 31/122
Loading...
200410049697.8
Hutchison Whampoa Pharmaceutics Enterprise Co., Ltd.
Cui Yumin
A61K 31/122
Loading...
An application of the irisin A and irisin B in preparing the sensitizer for chemicotherapy is disclosed.
35. 1689628 Medical purpose of creat extract
CN
02.11.2005
A61K 36/19 Loading...
A61K 36/19
Loading...
200410037476.9
Hutchison MediPharm Limited
Cai Yu
A61K 36/19
Loading...
The present invention relates to the medicine use of andrographis herb extract, and is especially the application of andrographis herb extract in preparing TNF-alpha and/or IL-1beta inhibitor as the medicine for treating ulcerous colitis and clonal disease.
36. 1676521 Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine
CN
05.10.2005
C07D 311/30 Loading...
C07D 311/30
Loading...
200410030938.4
Schlumber Pharmaceutical Enterprise Ltd.
Yan Xiaoqiang
C07D 311/30
Loading...
This invention relates to a kuh-seng ketone and its derivant, and the pharmacy use of its analog. It specifically relates to kuh-seng ketone and its vibrant and analog's use in the anticancer medicine. This invention also explores the new medical use of the kuh-seng ketone and its derivant and analogs.
37. 1676520 Kuh-seng flavone extract and preparation and use thereof
CN
05.10.2005
A61K 31/352 Loading...
A61K 31/352
Loading...
200410030937.X
Schlumber Pharmaceutical Enterprise Ltd.
Yan Xiaoqiang
A61K 31/352
Loading...
This invention relates to kuh-seng total ketone extractor that has TNF A and IL-I beta restrain effect, and its making method and the medicate combinations.
38. 1666985 Medical use of andrographolidume and its derivatives and analogs
CN
14.09.2005
A61K 31/365 Loading...
A61K 31/365
Loading...
200410008512.9
Hutchison Whampoa Medicine Co., Ltd.
Yan Xiaoqiang
A61K 31/365
Loading...
This invention relates to the following general expression compound or the medicine use of its prodrug. Concretely it relates to the general expression compound or its prodrug's use in preparing TNF-alphaand/or IL-1beta inhibitor. R1 stands for hydrogen, alkyl, aryl, cyclic hydrocarbon or heterocyclic hydrocarbon. R2 stands for the following chemical formula, R' stands for hydrogen, alkyl, aryl, hetero aryl, alkoxy, halogen group, amido or hydroxy group, R'' stands for hydrogen, alkyl, cyclic hydrocarbon, aryl, hetero aryl, alkoxy, halogen group or amido.
39. 1623547 Medical use of artificial lywrine
CN
08.06.2005
A61K 31/4745 Loading...
A61K 31/4745
Loading...
200310120747.2
Hutchison Medipharmal Enterprise Co., Ltd.
Yan Xiaoqiang
A61K 31/4745
Loading...
An application of pseudo-amarylline or its pharmacologically acceptable salt or precursor in preparing TNF-alpha and/or IL-1 beta depressant is disclosed.
40. 1589784 5-hydroxymethyl -2-furol and its derivative analogue medical use
CN
09.03.2005
A61K 31/341 Loading...
A61K 31/341
Loading...
03156433.X
Heji Huangpu Medicine Enterprise Co., Ltd.
Du Ying
A61K 31/341
Loading...
An application of 5-hydroxymethyl-2-furaldehyde, its derivative or salt, and its like or precursor in preparing medicine is disclosed.
41. 1565469 Cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation
CN
19.01.2005
A61K 31/7048 Loading...
A61K 31/7048
Loading...
03145773.8
Hutchison MediPharm Limited
Du Ying
A61K 31/7048
Loading...
The invention relates to a cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation, the oral pharmaceutical composition and preparation of its active constitution, the invention also relates to the process for preparing the oral pharmaceutical composition and preparation.
42. 1566124 Cornel extract and use thereof
CN
19.01.2005
A61K 36/40 Loading...
A61K 36/40
Loading...
03145774.6
Hutchison Whampoa Limited
Du Ying
A61K 36/40
Loading...
The invention relates to a cornel extract whose active compositions are morroniside and cornel, and their use in the preparation of medicinal preparation for treating or preventing aches or inflammation.

